Form D · Biotechnology
COMPUGEN LTD
Holon, L3 · CIK 0001119774
Offering snapshot reported Nov 22, 2021 · SEC filing
- Reported sold
- $20M Offering amount: $20M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 10, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 22, 2021 | Initial | $20,000,000 | No comparison | 1 | SEC filing |
| Oct 16, 2018 | Initial | $12,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-422015
Source: Form D, filed Nov 22, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Henry Adewoye | Executive |
| Yair Aharonowitz | Director |
| Jean Pierre Bizzari | Director |
| Kirk A. Christoffersen | Executive |
| Anat Cohen Dayag | Director, Executive |
| Oliver Froescheis | Executive |
| Gilead Halevy | Director |
| John Hunter | Executive |
| Ari Krashin | Executive |
| Zurit Levine | Executive |
| Arie Ovadia | Director |
| Eran Perry | Director |
| Kinneret Livnat Savitzky | Director |
| Paul Sekhri | Director |
| Yaron Turpaz | Executive |
| Sanford Zweifach | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
26 Harokmim Street Building D
Holon, L3, 5885849
Holon, L3, 5885849